Benjamin Haibe‐Kains

38.9k total citations · 11 hit papers
262 papers, 21.6k citations indexed

About

Benjamin Haibe‐Kains is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Benjamin Haibe‐Kains has authored 262 papers receiving a total of 21.6k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Molecular Biology, 78 papers in Cancer Research and 58 papers in Oncology. Recurrent topics in Benjamin Haibe‐Kains's work include Gene expression and cancer classification (70 papers), Bioinformatics and Genomic Networks (67 papers) and Cancer Genomics and Diagnostics (39 papers). Benjamin Haibe‐Kains is often cited by papers focused on Gene expression and cancer classification (70 papers), Bioinformatics and Genomic Networks (67 papers) and Cancer Genomics and Diagnostics (39 papers). Benjamin Haibe‐Kains collaborates with scholars based in Canada, United States and Belgium. Benjamin Haibe‐Kains's co-authors include Christos Sotiriou, Hugo J.W.L. Aerts, Christine Desmedt, John Quackenbush, Martine Piccart, Emmanuel Rios Velazquez, Ralph T. H. Leijenaar, Philippe Lambin, Patrick Großmann and Sherene Loi and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Benjamin Haibe‐Kains

246 papers receiving 21.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

2014 3.6k citations Benjamin Haibe‐Kains, John Quackenbush et al. profile →
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

2006 1.5k citations Christos Sotiriou, Sherene Loi et al. profile →
Similarity network fusion for aggregating data types on a genomic scale

2014 1.3k citations Benjamin Haibe‐Kains, Anna Goldenberg et al. profile →
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series

2007 726 citations Sherene Loi, Benjamin Haibe‐Kains et al. Clinical Cancer Research profile →
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

2008 654 citations Christos Sotiriou, Benjamin Haibe‐Kains et al. profile →
Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

2008 601 citations Benjamin Haibe‐Kains, Martine Piccart et al. Clinical Cancer Research profile →
Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade

2007 599 citations Sherene Loi, Benjamin Haibe‐Kains et al. profile →
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma

2015 547 citations Benjamin Haibe‐Kains et al. profile →
Robust Radiomics Feature Quantification Using Semiautomatic Volumetric Segmentation

2014 468 citations Benjamin Haibe‐Kains et al. profile →
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

2013 387 citations Sherene Loi, Sandra Pommey et al. profile →
Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer

2015 358 citations Benjamin Haibe‐Kains et al. profile →

Peers

Countries citing papers authored by Benjamin Haibe‐Kains

Since Specialization

Citations

This map shows the geographic impact of Benjamin Haibe‐Kains's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Haibe‐Kains with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Haibe‐Kains more than expected).

Fields of papers citing papers by Benjamin Haibe‐Kains

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Haibe‐Kains. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Haibe‐Kains. The network helps show where Benjamin Haibe‐Kains may publish in the future.

Co-authorship network of co-authors of Benjamin Haibe‐Kains

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Haibe‐Kains. A scholar is included among the top collaborators of Benjamin Haibe‐Kains based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Haibe‐Kains. Benjamin Haibe‐Kains is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health Data Nexus: an open data platform for AI research and education in medicine 2025 ·GigaScience ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Muhammad Mamdani, Alistair E. W. Johnson, (unknown), Tom Pollard, David Rotenberg, Benjamin Haibe‐Kains	0
2	Adenosine Uptake through the Nucleoside Transporter ENT1 Suppresses Antitumor Immunity and T-cell Pyrimidine Synthesis 2024 ·Cancer Research ·David Allard, (unknown), (unknown), (unknown), Farnoosh Abbas‐Aghababazadeh, (unknown), (unknown), Benjamin Haibe‐Kains, John Stagg	7
3	Bimodal Gene Expression in Patients with Cancer Provides Interpretable Biomarkers for Drug Sensitivity 2022 ·Cancer Research ·Wail Ba-Alawi, (unknown), Bo Li, (unknown), Petr Smirnov, Arvind Singh Mer, Linda Z. Penn, Benjamin Haibe‐Kains	5
4	Drug sensitivity prediction from cell line-based pharmacogenomics data: guidelines for developing machine learning models 2021 ·Briefings in Bioinformatics ·Hossein Sharifi-Noghabi, (unknown), Petr Smirnov, C. Suk-Yee Hon, (unknown), (unknown), Arvind Singh Mer, Martin Ester, Benjamin Haibe‐Kains	36
5	PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis 2021 ·Nucleic Acids Research ·(unknown), (unknown), Petr Smirnov, (unknown), (unknown), (unknown), Minoru Nakano, (unknown), (unknown), (unknown), Arvind Singh Mer, Eva Lin, Yihong Yu, Scott E. Martin, Marc Hafner, Benjamin Haibe‐Kains	20
6	Meta-Analysis of 1,200 Transcriptomic Profiles Identifies a Prognostic Model for Pancreatic Ductal Adenocarcinoma 2019 ·JCO Clinical Cancer Informatics ·Vandana Sandhu, Knut Jørgen Labori, Ayelet Borgida, Ilinca M. Lungu, John M.S. Bartlett, Sara Hafezi‐Bakhtiari, Robert E. Denroche, Gun Ho Jang, Danielle Pasternack, (unknown), (unknown), Julie M. Wilson, Elin H. Kure, Steven Gallinger, Benjamin Haibe‐Kains	7
7	Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts 2019 ·Cancer Research ·Arvind Singh Mer, Wail Ba-Alawi, Petr Smirnov, (unknown), (unknown), Janosch Ortmann, Ming‐Sound Tsao, David W. Cescon, Anna Goldenberg, Benjamin Haibe‐Kains	30
8	Modeling Cellular Response in Large-Scale Radiogenomic Databases to Advance Precision Radiotherapy 2019 ·Cancer Research ·Venkata Manem, (unknown), Ian C. P. Smith, Petr Smirnov, Victor Kofia, Mark Freeman, Marianne Koritzinsky, Mohamed E. Abazeed, Benjamin Haibe‐Kains, Scott V. Bratman	19
9	Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer 2019 ·Clinical Cancer Research ·Ruoshi Shi, Nikolina Radulovich, Christine Ng, Ni Liu, Hirotsugu Notsuda, Michael Cabanero, Sebastião N. Martins-Filho, Vibha Raghavan, Quan Li, Arvind Singh Mer, (unknown), Ming Li, Yu-Hui Wang, Laura Tamblyn, Nhu‐An Pham, Benjamin Haibe‐Kains, Geoffrey Liu, Nadeem Moghal, Ming‐Sound Tsao	204
10	SIGN: similarity identification in gene expression 2019 ·Bioinformatics ·Seyed Ali Madani Tonekaboni, Venkata Manem, Nehmé El-Hachem, Benjamin Haibe‐Kains	3
11	CrosstalkNet: A Visualization Tool for Differential Co-expression Networks and Communities 2018 ·Cancer Research ·Venkata Manem, George Alexandru Adam, Tina Gruosso, Mathieu Gigoux, Nicholas Bertos, Morag Park, Benjamin Haibe‐Kains	1
12	Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer 2018 ·Clinical Cancer Research ·Jennifer Haynes, Trevor D. McKee, (unknown), Yadong Wang, Cherry Leung, Deena M.A. Gendoo, Evelyne Lima‐Fernandes, Antonija Kreso, (unknown), Eva Szentgyörgyi, Douglass Vines, Benjamin Haibe‐Kains, Bradly G. Wouters, Ur Metser, David A. Jaffray, (unknown), Catherine O′Brien	17
13	Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy 2017 ·Cancer Research ·Nehmé El-Hachem, Deena M.A. Gendoo, Laleh Soltan Ghoraie, Zhaleh Safikhani, Petr Smirnov, Christina Chung, (unknown), (unknown), (unknown), (unknown), Ruth Isserlin, Gary D. Bader, Anna Goldenberg, Benjamin Haibe‐Kains	28
14	Tissue specificity of in vitro drug sensitivity 2017 ·Journal of the American Medical Informatics Association ·Fupan Yao, Seyed Ali Madani Tonekaboni, Zhaleh Safikhani, Petr Smirnov, Nehmé El-Hachem, Mark Freeman, Venkata Manem, Benjamin Haibe‐Kains	16
15	Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins 2017 ·Cancer Research ·Rosemary Yu, Joseph Longo, Jenna E. van Leeuwen, Peter Mullen, Wail Ba-Alawi, Benjamin Haibe‐Kains, Linda Z. Penn	53
16	Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis 2016 ·Cancer Research ·Deepak Mittal, Debottam Sinha, Deborah S. Barkauskas, Arabella Young, Murugan Kalimutho, Kimberley Stannard, Franco Caramia, Benjamin Haibe‐Kains, John Stagg, Kum Kum Khanna, Sherene Loi, Mark J. Smyth	142
17	CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer 2015 ·Cancer Research ·Martin Turcotte, Kathleen Spring, Sandra Pommey, Guillaume Chouinard, Isabelle Cousineau, Joshy George, Gregory M. Chen, Deena M.A. Gendoo, Benjamin Haibe‐Kains, Thomas Karn, Kurosh Rahimi, Cécile Le Page, Diane Provencher, Anne‐Marie Mes‐Masson, John Stagg	207
18	Loss of Pgc-1α expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation 2013 ·American Journal of Physiology-Endocrinology and Metabolism ·(unknown), Aurèle Besse‐Patin, (unknown), Sandra Kleiner, Dina Laznik-Bogoslavski, Christiane D. Wrann, Jorge L. Ruas, Benjamin Haibe‐Kains, Jennifer L. Estall	90
19	A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets 2013 ·Clinical Cancer Research ·Sophia Adamia, Benjamin Haibe‐Kains, Patrick M. Pilarski, Michal Bar‐Natan, Samuel Pevzner, Hervé Avet‐Loiseau, Laurence Lodé, Sigitas Verselis, Edward A. Fox, John P. Burke, Ilene Galinsky, Ibiayi Dagogo‐Jack, Martha Wadleigh, David P. Steensma, Gabriela Motyckova, Daniel J. DeAngelo, John Quackenbush, Richard M. Stone, James D. Griffin	79
20	Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling 2012 ·Clinical Cancer Research ·Hatem A. Azim, Stefan Michiels, Philippe L. Bédard, Sandeep K. Singhal, Carmen Criscitiello, Michail Ignatiadis, Benjamin Haibe‐Kains, Martine Piccart, Christos Sotiriou, Sherene Loi	278

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact